FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Actavis Trelstar Recall

Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-15…

Actavis Inc · Parsippany, NJ

Risk level
Class II
Reported by FDA
Feb 19, 2014
Recall ID
D-1085-2014
Check your lot numberHow we source this data

Summary

Actavis recalled Trelstar starting Dec 9, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1085-2014 on Feb 19, 2014. Reason: Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg. Status: Terminated.

Why it was recalled

Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.

Product description

Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus MIXJECT Single-Dose Delivery System containing 2 mL Sterile Water for Injection, USP per carton (NDC 52544-188-76), 11.25 mg, Rx Only, Dist. By: Watson Pharma, Inc., Morristown, NJ 07962, Mfd. by: Debio RP, CH-1920 Martigny, Switzerland.

Lot numbers, UPCs & expiration codes

Lot #: 13J081, Exp 05/15

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1085-2014
Classification
Class II
Status
Terminated
Recall initiated
Dec 9, 2013
FDA report date
Feb 19, 2014
Quantity
99 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis Inc

Original FDA data

Every field from FDA enforcement report D-1085-2014, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
67386
Address
400 Interpace Pkwy
Code information
Lot #: 13J081, Exp 05/15
Postal code
07054-1120
Report date
Feb 19, 2014
Product type
Drugs
Recall number
D-1085-2014
Classification
Class II
Recalling firm
Actavis Inc
Product quantity
99 cartons
Termination date
Aug 4, 2014
Reason for recall
Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus MIXJECT Single-Dose Delivery System containing 2 mL Sterile Water for Injection, USP per carton (NDC 52544-188-76), 11.25 mg, Rx Only, Dist. By: Watson Pharma, Inc., Morristown, NJ 07962, Mfd. by: Debio RP, CH-1920 Martigny, Switzerland.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Dec 9, 2013
Initial firm notification
Letter
Center classification date
Feb 11, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1085-2014, published Feb 19, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls